Low NDI Notice Compliance Sets Stage For Enforcement – FDA’s Fabricant

The volume of noncompliant supplement ingredients on the market likely will prompt an uptick in enforcement after FDA releases its NDI notification guidance, which will draw attention to the problem, dietary supplement program chief Daniel Fabricant says.